ULGX Financial Facts

Net loss per common share - basic (in dollars per share): -0.02
Diluted (in shares): 21.84M
See Full Income Statement

Total current liabilities: 6.13M
Total shareholders' equity: -8.06M
See Full Balance Sheet

Urologix, Inc. (ULGX) Earnings

  |   Expand Research on ULGX
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +4.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS 0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/7/25 Q424 N/AN/A N/A N/AN/A N/A N/A N/A
11/18/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
11/11/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
10/30/24 Q324 N/AN/A N/A N/AN/A N/A N/A N/A
8/26/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
8/21/24 Q224 N/AN/A N/A N/AN/A N/A N/A N/A
5/15/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
2/9/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A